hypercalcemia

Summary

Summary: Abnormally high level of calcium in the blood.

Top Publications

  1. ncbi Minimally symptomatic severe hypercalcaemia in a patient with parathyroid carcinoma
    Aisha Sheikh
    Department of Medicine, Aga Khan University Hospital, Karachi
    J Pak Med Assoc 56:40-1. 2006
  2. ncbi [Parathyroid carcinoma]
    Robert Krysiak
    Slaski Uniwersytet Medyczny, Klinika Chorób Wewnetrznych i Farmakologii Klinicznej, Katedry Farmakologii
    Pol Merkur Lekarski 23:145-50. 2007
  3. ncbi Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    D L Lacey
    Department of Pathology, Amgen, Inc, Thousand Oaks, California 91320 1789, USA
    Cell 93:165-76. 1998
  4. ncbi Improvement in hypercalcemia with cinacalcet after kidney transplantation
    Titte R Srinivas
    Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL 32610 0224, USA
    Clin J Am Soc Nephrol 1:323-6. 2006
  5. ncbi Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet
    N Leca
    Department of Medicine, SUNY University at Buffalo, NY, USA
    Am J Transplant 6:2391-5. 2006
  6. ncbi Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial
    Susan L Greenspan
    University of Pittsburgh, Osteoporosis Prevention and Treatment Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Intern Med 146:326-39. 2007
  7. ncbi What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy
    Bill Chiu
    Department of Surgery, Division of Gastrointestinal and Endocrine Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Surgery 140:418-22. 2006
  8. ncbi Cinacalcet for hyperparathyroidism in pregnancy and puerperium
    Carmen Horjus
    Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands
    J Pediatr Endocrinol Metab 22:741-9. 2009
  9. ncbi The detrimental role of inducible nitric oxide synthase in the pulmonary edema caused by hypercalcemia in conscious rats and isolated lungs
    Hsing I Chen
    Institute of Medical Sciences and of Integrative Physiology and Clinical Sciences, Tzu Chi University, Hualien, Taiwan
    J Biomed Sci 15:227-38. 2008
  10. ncbi Parathyroid surgery in pregnancy: review of the literature and localization by aspiration for parathyroid hormone levels
    P Pothiwala
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA
    J Perinatol 29:779-84. 2009

Research Grants

Detail Information

Publications249 found, 100 shown here

  1. ncbi Minimally symptomatic severe hypercalcaemia in a patient with parathyroid carcinoma
    Aisha Sheikh
    Department of Medicine, Aga Khan University Hospital, Karachi
    J Pak Med Assoc 56:40-1. 2006
    ..Before surgery he was managed with rehydration, diuretics and pamidronate infusion. Five months post surgery the serum calcium levels are normal and renal function has improved...
  2. ncbi [Parathyroid carcinoma]
    Robert Krysiak
    Slaski Uniwersytet Medyczny, Klinika Chorób Wewnetrznych i Farmakologii Klinicznej, Katedry Farmakologii
    Pol Merkur Lekarski 23:145-50. 2007
    ..Most patients with parathyroid carcinoma suffer from symptoms related to marked hypercalcemia; the incidence of associated renal, bone, gastrointestinal, neuromuscular and psychological symptoms is much ..
  3. ncbi Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    D L Lacey
    Department of Pathology, Amgen, Inc, Thousand Oaks, California 91320 1789, USA
    Cell 93:165-76. 1998
    ..and short-term administration into normal adult mice results in osteoclast activation associated with systemic hypercalcemia. These data suggest that OPGL is an osteoclast differentiation and activation factor...
  4. ncbi Improvement in hypercalcemia with cinacalcet after kidney transplantation
    Titte R Srinivas
    Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL 32610 0224, USA
    Clin J Am Soc Nephrol 1:323-6. 2006
    ..Ten kidney transplant recipients and one kidney-pancreas recipient with persistent post-Tx hypercalcemia (serum calcium [SCa] > 10...
  5. ncbi Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet
    N Leca
    Department of Medicine, SUNY University at Buffalo, NY, USA
    Am J Transplant 6:2391-5. 2006
    ..Patients whose HPT is associated with hypercalcemia pose a difficult therapeutic dilemma which often requires parathyroidectomy...
  6. ncbi Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial
    Susan L Greenspan
    University of Pittsburgh, Osteoporosis Prevention and Treatment Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Intern Med 146:326-39. 2007
    ..Recombinant human parathyroid hormone (1-84) (PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation...
  7. ncbi What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy
    Bill Chiu
    Department of Surgery, Division of Gastrointestinal and Endocrine Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Surgery 140:418-22. 2006
    ..We hypothesized that nonlocalizing sestamibi scans would correlate with multigland disease and persistent primary hyperparathyroidism...
  8. ncbi Cinacalcet for hyperparathyroidism in pregnancy and puerperium
    Carmen Horjus
    Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands
    J Pediatr Endocrinol Metab 22:741-9. 2009
    ..The second patient presented with hypertension and symptomatic hypercalcemia (Ca(corr) 3.96 mmol/l) in the 32nd week of pregnancy...
  9. ncbi The detrimental role of inducible nitric oxide synthase in the pulmonary edema caused by hypercalcemia in conscious rats and isolated lungs
    Hsing I Chen
    Institute of Medical Sciences and of Integrative Physiology and Clinical Sciences, Tzu Chi University, Hualien, Taiwan
    J Biomed Sci 15:227-38. 2008
    We aim to test the hypothesis that hypercalcemia produces pulmonary edema (PE) and to elucidate the mechanism. Experimentations were carried out in conscious rats and isolated perfused rat lungs...
  10. ncbi Parathyroid surgery in pregnancy: review of the literature and localization by aspiration for parathyroid hormone levels
    P Pothiwala
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA
    J Perinatol 29:779-84. 2009
    ..To review the management of primary hyperparathyroidism in pregnant women by focusing on the use of preoperative localization procedures and minimally invasive parathyroid surgery during pregnancy...
  11. ncbi Subcutaneous fat necrosis of the newborn: a review of 11 cases
    A D Burden
    Department of Dermatology, Hospital for Sick Children, Toronto, Ontario, Canada
    Pediatr Dermatol 16:384-7. 1999
    ..The frequency with which hypercalcemia develops as a complication is uncertain...
  12. ncbi Post-operative subcutaneous fat necrosis in a newborn: a case report
    Mustafa Ali Akin
    Department of Neonatology, Erciyes University School of Medicine, Kayseri, Turkey
    Fetal Pediatr Pathol 30:363-9. 2011
    ..The ScFN tends to improve spontaneously with or without some severe complications such as hypercalcemia. The ScFN may occur as iatrogenic after hypothermic surgical interventions...
  13. ncbi The diagnosis and management of asymptomatic primary hyperparathyroidism
    Shonni J Silverberg
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Nat Clin Pract Endocrinol Metab 2:494-503. 2006
    ....
  14. ncbi Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature
    Julie Thao Tran
    Department of Dermatology, Children's Hospital Medical Center of Cincinnati, University of Cincinnati, Cincinnati, Ohio, USA
    Pediatr Dermatol 20:257-61. 2003
    ..Rare complications such as hypercalcemia, thrombocytopenia, hypertriglyceridemia, and hypoglycemia have been reported...
  15. ncbi Familial benign hypocalciuric hypercalcemia
    Ghada El-Hajj Fuleihan
    Calcium Metabolism and Osteoporosis Program, American University of Beirut Medical Center, Lebanon
    J Bone Miner Res 17:N51-6. 2002
    ..Clinical, biochemical, and pathophysiological observations over several decades on familial benign hypocalciuric hypercalcemia (FBHH) ultimately culminated in the 1990s in the unraveling of the genetic basis of this calcium-sensing ..
  16. ncbi Medical treatment of malignancy-associated hypercalcemia
    F Lumachi
    Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, 35128 Padova, Italy
    Curr Med Chem 15:415-21. 2008
    Malignancy-associated hypercalcemia (MAH) is the commonest cause of hypercalcemia in hospitalized patients. Its incidence is 15 cases per 100,000 person-year...
  17. ncbi Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment
    Gerald S Braun
    Int J Dermatol 46:1315-7. 2007
  18. ncbi Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
    Z Nikolic-Tomasevic
    Institute for Oncology and Radiology of Serbia, Belgrade, Yugoslavia
    Oncology 60:123-6. 2001
    The most serious, potentially life-threatening manifestation of 'flare' is hypercalcemia, registered in 4-5% of breast cancer patients with bone metastases, usually during the first few weeks of tamoxifen treatment...
  19. ncbi Extracellular calcium-sensing receptor: structural and functional features and association with diseases
    O M Hauache
    Laboratório de Endocrinologia Molecular, Disciplina de Endocrinologia, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brasil
    Braz J Med Biol Res 34:577-84. 2001
    ..association of genetic human diseases with inactivating and activating CaR mutations: familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism are caused by CaR-inactivating mutations, whereas autosomal dominant ..
  20. ncbi Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients
    A Akcay
    Department of Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey
    Transplant Proc 37:3103-5. 2005
    ..PTE appeared in 43 (27.7%) patients during the follow-up period. Sixty-three (40.6%) patients developed hypercalcemia (corrected serum calcium level > or =10.2 mg/dL)...
  21. ncbi PTH-related peptide (PTHrP) in hypercalcemia
    Gregory R Mundy
    Vanderbilt Center for Bone Biology, 1235 Medical Research Building IV, Nashville, TN 37232 0575, USA
    J Am Soc Nephrol 19:672-5. 2008
    ..Parathyroid hormone-related peptide has become a useful diagnostic tool in the differential diagnosis of hypercalcemia, and approaches to inhibit its expression or its effects by malignant cells hold promise for treating the ..
  22. ncbi Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients
    F N Ozdemir
    Department of Nephrology, Baskent University Hospital, Ankara, Turkey
    Transplant Proc 38:480-2. 2006
    b>Hypercalcemia is a common problem in renal transplant recipients, although in most cases, spontaneous resolution occurs within 1 year after renal transplantation...
  23. ncbi An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
    L D'Souza-Li
    Department of Medicine, McGill University and Royal Victoria Hospital, Montreal, Canada
    Hum Mutat 18:411-21. 2001
    We studied family members of a large kindred expressing both familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) and found, by PCR amplification of the extracellular calcium-sensing receptor (CASR) ..
  24. ncbi Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage
    Govinda Pillai Arumugam
    Department of Medical Biochemistry, Dr.A.L.M. Post-Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, 600 113, India
    J Bone Miner Metab 24:243-7. 2006
    ..advanced breast cancer treated with tamoxifen the most common life-threatening metabolic complication of flare hypercalcemia developed. All the hypercalcemic patients had osteolytic or mixed lytic and blastic bone metastases...
  25. ncbi Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis
    Chie Kawahara
    First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807-8555, Kitakyushu, Japan
    J Bone Miner Metab 22:159-62. 2004
  26. ncbi Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy
    J Tfelt-Hansen
    Division of Endocrinology, Diabetes and Hypertension, Department of Medicine and Membrane Biology Program, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Endocrinology 145:1211-7. 2004
    Using H-500 rat Leydig cancer cells as a model of humoral hypercalcemia of malignancy (HHM), we previously showed that high Ca(2+) induces PTH-related peptide (PTHrP) secretion via the calcium-sensing receptor (CaR) and mitogen- and ..
  27. ncbi Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK
    Richard Morgan
    Postgraduate Medical School, University of Surrey, UK
    Mol Cancer 5:51. 2006
    ..These results suggest that the low levels of p38 MAPK expression in FA-6 cells may serve to reduce their sensitivity to high concentrations of external Ca2+ that would otherwise block proliferation...
  28. ncbi Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection
    Robert E Miller
    Department of Cancer Biology, Amgen Washington, 1201 Amgen Court West, Seattle, WA 98119, USA
    J Immunol 179:266-74. 2007
    ..by RANK-Fc on osteoclast function was determined by inhibition of vitamin D(3) (1,25(OH)(2)D(3))-induced hypercalcemia. Mice were injected with a single dose of 0, 10, 100, 500, or 1000 microg of RANK-Fc; 100 microg of OPG-Fc; or ..
  29. ncbi A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose
    Michael T Sim
    Department of Internal Medicine, University of California Davis, Sacramento, CA, USA
    J Med Toxicol 4:25-9. 2008
    ..treated for a suspected verapamil overdose with continuous calcium chloride infusion, resulting in severe hypercalcemia of 32.3 mg/dL (8.07 mmol/L) with a normal range of 8.6-10.5 mg/dL (2.15-2.63 mmol/L)...
  30. ncbi A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia
    Nicholas Shukeir
    Department of Medicine, Physiology, and Oncology, McGill University Health Centre, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
    Cancer Res 64:5370-7. 2004
    ..parathyroid hormone-related protein (PTHrP), which is the main pathogenetic factor responsible for hypercalcemia of malignancy...
  31. ncbi Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review
    Vivian Y Pao
    Endocrine Metabolism Section, Department of Veterans Affairs Medical Center, University of California San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
    J Bone Miner Res 24:1135-9. 2009
    ..with stable chronic lymphocytic leukemia (CLL), end-stage renal disease (ESRD), and NSF who presented with hypercalcemia in 2006. Before onset of renal insufficiency in 2002, serum calcium, phosphorus, and PTH levels were normal...
  32. ncbi The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
    Lakshmi Kantham
    Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Physiol Endocrinol Metab 297:E915-23. 2009
    ..C(-)P(-) mice show increased susceptibility to developing hypercalcemia with all three challenges compared with the other two genotypes, whereas C(+)P(-) mice defend against ..
  33. ncbi Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients
    Pieter Evenepoel
    Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium
    Clin J Am Soc Nephrol 5:2085-92. 2010
    b>Hypercalcemia is a common complication in renal transplant recipients and has been associated with nephrocalcinosis and poor graft outcome...
  34. ncbi Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism
    Hema Padmanabhan
    Endocrine Section, Department of Medicine, Veterans Affairs Medical Center, Salem, VA 24153, USA
    South Med J 103:272-5. 2010
    ..there is no established medical therapy for this condition, pharmacotherapy with agents such as cinacalcet could be a preferred alternative in a subset of patients with persistent hypercalcemia after one or more surgical interventions.
  35. ncbi A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia
    Masahiko Sato
    Lilly Research Laboratories, Indianapolis, IN 46285, USA
    J Bone Miner Res 25:1326-36. 2010
    ..be beneficial for osteoporosis and other indications, but their narrow therapeutic window between efficacy and hypercalcemia has limited their clinical utility...
  36. ncbi First report of ectopic ACTH syndrome and PTHrP-induced hypercalcemia due to a hepatoblastoma in a child
    Thomas G P Grunewald
    Department of Pediatrics, Klinikum rechts der Isar, Technische Universitat Munchen, Kolner Platz 1, D 80804 Munich, Germany
    Eur J Endocrinol 162:813-8. 2010
    ..Only occasionally, endocrine-active tumors develop directly from hepatic tissue, and may lead to paraneoplastic syndromes (PNS). PNS mostly accompany malignancy of adulthood and are exceedingly rare in children...
  37. ncbi Aggressive small cell carcinoma of the ovary, hypercalcemic type with hypercalcemia in pregnancy, treated with conservative surgery and chemotherapy
    Timothy Chad McCormick
    Department of Obstetrics and Gynecology, University of Missouri Kansas City, Kansas City, MO 64108, USA
    Int J Gynecol Cancer 19:1339-41. 2009
    ..Small cell carcinoma of the ovary, hypercalcemic type is a rare and aggressive malignancy found in reproductive-age women...
  38. ncbi Hypercalcemia and acute renal failure in milk-alkali syndrome: a case report
    Kimberly Ulett
    Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Hosp Med 5:E18-20. 2010
    ..The classic description includes hypercalcemia, metabolic alkalosis, and renal failure...
  39. ncbi Hypercalcemia in cancer patients: pathobiology and management
    L Santarpia
    Translational Research Unit, Department of Oncology Hospital of Prato and Istituto Toscana Tumori, Florence, Italy
    Horm Metab Res 42:153-64. 2010
    b>Hypercalcemia is the most common life-threatening metabolic disorder associated with cancer, occurring in approximately 10-30% of all patients with neoplastic disease, although it occurs much less often in the pediatric setting...
  40. ncbi Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM)
    Noritoshi Kobayashi
    Department of Gastroenterology, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Japan
    J Hepatobiliary Pancreat Surg 15:531-5. 2008
    We report a rare case of adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) in which parathyroid hormone-related protein (PTH-rP) was identified as the causative factor of hypercalcemia...
  41. ncbi Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis
    B Akinci
    Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir, Turkey
    Exp Clin Endocrinol Diabetes 117:142-5. 2009
    ..FDA) for the treatment of patients with secondary hyperparathyroidism on maintenance dialysis and hypercalcemia in patients with parathyroid cancer. It is used also in Europe for both indications...
  42. ncbi Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy
    M Mangin
    Department of Medicine, Yale University, New Haven, CT 06510
    Proc Natl Acad Sci U S A 85:597-601. 1988
    Humoral hypercalcemia of malignancy is a common paraneoplastic syndrome that appears to be mediated in many instances by a parathyroid hormone-like peptide...
  43. ncbi [Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia]
    Satoshi Washino
    Department of Urology, Jichi Saitama Medical Center
    Nihon Hinyokika Gakkai Zasshi 99:703-8. 2008
    We report two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia. Case 1; a 54 year old female with primary squamous cell carcinoma (SCC) of right ureter showed marked hypercalcemia and leukocytosis...
  44. ncbi Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism
    Carlos Bergua
    Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Spain
    Transplantation 86:413-7. 2008
    Persistent secondary hyperparathyroidism (SHP) is the most frequent cause of hypercalcemia observed in approximately 10% of renal transplanted (RT) patients 1 year after surgery...
  45. ncbi Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice
    Rachel A Davey
    Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia
    J Bone Miner Res 23:1182-93. 2008
    ..Furthermore, the peak in serum total calcium after calcitriol [1,25(OH)(2)D(3)]-induced hypercalcemia was substantially greater in global CTRKOs compared with controls...
  46. ncbi A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression
    L J Suva
    Science 237:893-6. 1987
    Humoral hypercalcemia of malignancy is a common complication of lung and certain other cancers. The hypercalcemia results from the actions of tumor factors on bone and kidney...
  47. ncbi Humoral hypercalcemia complicating adenocarcinoma of the sigmoid colon: report of a case
    Jun Sakata
    Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Niigata 951-8510, Japan
    Surg Today 35:692-5. 2005
    Humoral hypercalcemia can arise from a variety of malignancies, but its association with primary colorectal carcinoma is rare, with only 20 such cases documented in the English-language literature to date...
  48. ncbi Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer
    Nicholas Shukeir
    Department of Medicine, Physiology and Oncology, McGill University Health Centre, Montreal, Quebec, H3A 1A1 Canada
    Cancer Res 63:2072-8. 2003
    ..PTHrP (MatLyLu-PTHrP cells)], which is known to be the major pathogenetic factor for malignancy-associated hypercalcemia. MatLyLu-PTHrP cells were inoculated s.c...
  49. ncbi A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy
    Kenji Kawada
    Department of Oncology/Hematology, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan
    Jpn J Clin Oncol 35:28-33. 2005
    BACKGROUND: Hypercalcemia of malignancy is a serious complication of cancer...
  50. ncbi ST-segment elevation: a common finding in severe hypercalcemia
    Laszlo Littmann
    J Electrocardiol 40:60-2. 2007
  51. ncbi Hypercalcemia due to vitamin D intoxication with clinical features mimicking acute myocardial infarction
    Naoto Ashizawa
    Division of Cardiovascular Medicine, Department of Translational Medical Sciences, Course of Medical and Dental Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki
    Intern Med 42:340-4. 2003
    We report a case of hypercalcemia in an elderly patient due to vitamin D intoxication with clinical features and electrocardiogram (ECG) findings mimicking acute myocardial infarction...
  52. ncbi Sarcoidosis-related hypercalcemia in 3 chronic hemodialysis patients
    A Huart
    Nephrology, Hemodialysis and Multi-Organ Transplantation Department, CHU Rangueil, , France
    Clin Nephrol 65:449-52. 2006
    b>Hypercalcemia is a frequent complication in chronic hemodialysis (CHD) patients. A rare cause of this condition is sarcoidosis, and has only been reported 6 times in CHD...
  53. ncbi Severe refractory hypercalcaemia in HTLV-1 infection
    C Mark B Edwards
    Department of Diabetes and Endocrinology, Central Middlesex Hospital, London, UK
    J R Soc Med 96:126-7. 2003
  54. ncbi Parathyroid carcinoma: difficult management options
    A Bhansali
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012, India
    Indian J Cancer 39:119-22. 2002
    ..We report a patient, who presented with palpable mass in the neck and severe hypercalcemia. He underwent debulking surgery and received allendronate, calcitonin, dacarbazine followed by in- situ ..
  55. ncbi Treatment of cancer-related hypercalcemia: the role of gallium nitrate
    Brian Leyland-Jones
    Department of Oncology, McGill University, Montreal, Quebec, Canada
    Semin Oncol 30:13-9. 2003
    b>Hypercalcemia is a common, life-threatening metabolic disorder that can be associated with cancer. Its pathophysiology includes enhanced osteoclastic bone resorption and decreased renal excretion of extracellular calcium...
  56. ncbi Evaluation and management of hypercalcemia
    Erin Hutton
    Jefferson City Medical Group, Jefferson City, MO, USA
    JAAPA 18:30-5. 2005
  57. ncbi A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
    C Ho
    Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Nat Genet 11:389-94. 1995
    ..Casr+/- mice, analogous to humans with familial hypocalciuric hypercalcemia, had benign and modest elevations of serum calcium, magnesium and parathyroid hormone levels as well as ..
  58. ncbi Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19
    T Inukai
    Department of Pediatrics, University of Yamanashi, School of Medicine, Yamanashi, Japan
    Leukemia 21:288-96. 2007
    b>Hypercalcemia is relatively rare but clinically important complication in childhood leukemic patients...
  59. ncbi Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells
    Kisato Nosaka
    Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan
    Blood 99:634-40. 2002
    b>Hypercalcemia is one of the most frequent and serious complications in patients with adult T-cell leukemia (ATL) and is due to marked bone resorption by accumulation of osteoclasts (OCLs)...
  60. ncbi Multiple myeloma/hypercalcemia
    Babatunde O Oyajobi
    University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology MSC 7762, San Antonio, Texas 78229 3900, USA
    Arthritis Res Ther 9:S4. 2007
    ..b>Hypercalcemia remains the most frequent metabolic complication of myeloma in patients, and excessive osteolysis plays a ..
  61. ncbi HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia
    Sabiha Shahnaz
    Department of Medicine, Mount Sinai Services, Queens Hospital Center, Jamaica, NY 11432, USA
    J Gen Intern Med 22:420-3. 2007
    ..Since the initial description of human T cell lymphotropic virus (HTLV-1), clusters of this infection have been detected globally. Unlike HIV infection, most patients infected with HTLV-1 remain asymptomatic throughout their lifetime...
  62. ncbi [Malignant humoral hypercalcemia associated with angiotropic large B cell lymphoma]
    B Knobel
    Department of Medicine B, Edith Wolfson Medical Center, Holon, Israel
    Harefuah 140:204-6, 287. 2001
    ..malignant lymphomatosis associated with parathyroid hormone related protein (PTH-rP) induced humoral hypercalcemia have been published. Our extraordinary case was diagnosed mainly by liver biopsy...
  63. ncbi [Humoral hypercalcemia revealing a malignant non hodgkin lymphoma]
    T Amezyane
    Clinique Medicale, Hôpital d Instruction des Armées du Val de Grâce, 00446 Armées Paris cedex, France
    Ann Endocrinol (Paris) 69:58-62. 2008
    b>Hypercalcemia is a rare complication of non-Hodgkin lymphoma. Usually, hypercalcemia occurs late in the disease course, except for high-grade lymphoma...
  64. ncbi Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy)
    Kanji Sato
    Field of Pathophysiology and Treatment for Thyroid and Parathyroid Diseases, Division of Internal Medicine, Graduate School of Medicine, Tokyo Women s Medical University, Shinjuku ku, Tokyo, Japan
    Endocr J 55:959-66. 2008
    b>Hypercalcemia during pregnancy or after delivery is uncommon, and mostly associated with primary hyperparathyroidism (PHPT). If unrecognized, it may increase maternal and fetal morbidity...
  65. ncbi The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication
    D C Lee
    Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY 11030, USA
    J Toxicol Clin Toxicol 36:719-21. 1998
    Pamidronate disodium, a bone resorption inhibitor through osteoclast mediation, has been used to treat chronic hypercalcemia secondary to malignancy and chronic renal failure...
  66. ncbi A new missense mutation in the CASR gene in familial interstitial lung disease with hypocalciuric hypercalcemia and defective granulocyte function
    Maurits Demedts
    Am J Respir Crit Care Med 177:558-9. 2008
  67. ncbi Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children
    I Schmid
    Kinderklinik and Kinderpoliklinik, Dr von Haunersches Kinderspital, University of Munich, Germany
    Klin Padiatr 213:30-4. 2001
    Severe symptomatic hypercalcemia is a rare event in children with malignancies. Up to now there is limited experience treating childhood hypercalcemia with bisphosphonates in addition to calcitonin...
  68. ncbi Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis
    Simona Dionisi
    Department of Clinical Sciences, University of Rome La Sapienza, Italy
    Mayo Clin Proc 77:866-9. 2002
    ..of parathyroid cancer, parathyroid adenomas, and pancreatic gastrinoma, who presented with an episode of acute hypercalcemia. The rapid parathyroid hormone assay provided a basis for the diagnosis of parathyroid hyperfunction...
  69. ncbi Small cell carcinoma of the prostate with hypercalcemia
    Kisaburo Hanazawa
    Department of Urology, Juntendo University Urayasu Hospital, Chiba, Japan
    Int J Urol 12:108-10. 2005
    We present a case of small cell prostate carcinoma with hypercalcemia in a 75-year-old man. He was diagnosed as having stage T3bN1M0 adenocarcinoma of the prostate...
  70. ncbi Radioguided parathyroidectomy for recurrent parathyroid cancer
    Kimberly Placzkowski
    Department of Medicine, University of Wisconsin, Madison, WI 53792, USA
    Clin Nucl Med 32:358-60. 2007
    ..A 61-year-old woman presented to our center with persistent hypercalcemia (17...
  71. ncbi An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations
    Noriko Makita
    Department of Endocrinology and Nephrology, University of Tokyo School of Medicine 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Proc Natl Acad Sci U S A 104:5443-8. 2007
    ..inactivation of CaSR or its inhibition by antibody blocking results in either familial hypocalciuric hypercalcemia or acquired hypocalciuric hypercalcemia (AHH), respectively...
  72. ncbi Hypocalciuric hypercalcemia and autoantibodies against the calcium-sensing receptor
    Michael R Rickels
    N Engl J Med 351:2237-8; author reply 2237-8. 2004
  73. ncbi Calcimimetics and calcilytics--fooling the calcium receptor
    Simon J Steddon
    Department of Renal Medicine and Transplantation, Bart s and The London NHS Trust, London, UK
    Lancet 365:2237-9. 2005
    ..Drugs acting on the CaR might treat other disorders of bone remodelling, including osteoporosis. CaR expression in tissues beyond those involved in mineral ion homoeostasis should remain an important focus of research...
  74. ncbi Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor
    J Carl Pallais
    Department of Endocrinology, Massachusetts General Hospital, Boston, MA 02114, USA
    N Engl J Med 351:362-9. 2004
  75. ncbi Hypocalciuric hypercalcemia and autoantibodies against the calcium-sensing receptor
    Nader Shakibai
    N Engl J Med 351:2237-8; author reply 2237-8. 2004
  76. ncbi Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome
    George L Irvin
    DeWitt Daughtry Family Department of Surgery, University of Miami Jackson Memorial Hospital, P O Box 016310 M 875, Miami, FL 33101, USA
    World J Surg 28:1287-92. 2004
    ..There was no statistical difference in the overall recurrence rates ( p = 0.23). The QPTH-guided parathyroidectomy identifies MGD and allows an improved success rate with the same low recurrence rate when compared to the results of BNE...
  77. ncbi Acute hyperparathyroidism: our experience with 36 cases
    G Gasparri
    III Department of General and Oesophageal Surgery, University of Torino, Italy
    Ann Ital Chir 75:321-4. 2004
    OBJECTIVES: Acute hypercalcemia is a serious condition and represents a physician-surgical emergency: the difficulty in setting a precise diagnosis is due to several possibilities that can cause the condition...
  78. ncbi Primary hyperparathyroidism in pediatric patients
    Josh Kollars
    Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Pediatrics 115:974-80. 2005
    ..had an elevated parathyroid hormone (PTH) level, and 15% had an inappropriately normal PTH level during hypercalcemia. Serum calcium was elevated in all patients except for 2 with multiple endocrine neoplasma (MEN)-IIA and 1 ..
  79. ncbi Primary hyperparathyroidism presumably caused by chronic parathyroiditis manifesting from hypocalcemia to severe hypercalcemia
    Sumiko Furuto-Kato
    Kishiwada City Hospital, Osaka
    Intern Med 44:60-4. 2005
    ..Despite the operation, hypercalcemia and high levels of intact PTH persisted. Six weeks later total parathyroidectomy was done to induce remission...
  80. ncbi [Dementia in parathyroid disease]
    Yukihiko Washimi
    Department of Neurology, Chubu National Hospital
    Nippon Rinsho 62:349-52. 2004
  81. ncbi Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors
    Etsuro Onuma
    Pharmaceutical Department IV, Chugai Research Laboratories, Chugai Pharmaceutical, CO, Ltd, Kanagawa, Japan
    Clin Cancer Res 11:4198-203. 2005
    PURPOSE: Bisphosphonate and calcitonin lower blood calcium in humoral hypercalcemia of malignancy (HHM) by suppressing osteoclastic bone resorption, but repeated administration of these drugs often leads to relapse...
  82. ncbi [Disorders of calcium metabolism during pregnancy and breast feeding]
    Jolanta Jurczynska
    Klinika Endokrynologii Instytutu Endokrynologii Uniwersytetu Medycznego, Lodzi
    Ginekol Pol 76:240-4. 2005
    ..The pharmacotherapy involves diuretics, fluids and oral phosphates. Bisphosphonates are contraindicated. Parathyroid surgery may be performed in the second trimester of pregnancy...
  83. ncbi Clinical inquiries. How should you evaluate elevated calcium in an asymptomatic patient?
    Bikas Sharma
    Carilion Health System Family Medicine Residency, Roanoke, VA, USA
    J Fam Pract 57:267-9. 2008
  84. ncbi Multiglandular parathyroid carcinoma: a case report and brief review
    Prem Sahasranam
    Division of Endocrinology and Department of Pathology, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    South Med J 100:841-4. 2007
    ..A better knowledge and understanding of this condition would aid in early diagnosis and possibly increase the survival rate...
  85. ncbi Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection
    James J Mezhir
    Department of Surgery, The University of Chicago, 5841 South Maryland Avenue, Mail Code 5031, Chicago, Illinois 60637, USA
    J Hepatobiliary Pancreat Surg 14:410-3. 2007
    ..Patients with parathyroid cancer are frequently plagued by severe hypercalcemia, which is often refractory to medical therapy...
  86. ncbi [Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism]
    Toshitsugu Sugimoto
    Nippon Naika Gakkai Zasshi 96:662-8. 2007
  87. ncbi [Differential diagnosis of hypercalcemia]
    Yasuhiro Takeuchi
    Nippon Naika Gakkai Zasshi 96:656-61. 2007
  88. ncbi Hypercalcemia in an 11-year-old girl
    Teresa A Nimmo
    Department of Endocrinology, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas 72202, USA
    Endocr Pract 13:198-201. 2007
  89. ncbi Mania in a case of hyperparathyroidism
    Scott W Brown
    Eastern Virginia Medical School, Dept of Psychiatry and Behavioral Sciences, 825 Fairfax Ave, Norfolk, VA 23507, USA
    Psychosomatics 48:265-8. 2007
    Psychiatric manifestations of primary hyperparathyroidism are mediated by hypercalcemia. To date, most evidence indicates that hypercalcemia and increased cerebrospinal-fluid calcium levels produce depression symptoms...
  90. ncbi [Hypercalcemia (with treatment)]
    Dominique Prie
    Laboratoire d exploration fonctionnelle, Hopital Necker Enfants Malades, 75743 Paris Cedex 15
    Rev Prat 56:1827-33. 2006
  91. ncbi Causes of hypercalcemia in a population of military veterans in the United States
    Elan M Newman
    Department of Surgery, San Diego Veterans Affairs Medical Center, San Diego, California 92161, USA
    Endocr Pract 12:535-41. 2006
    OBJECTIVE: To determine the various causes of hypercalcemia in a population of US veterans at the San Diego Veterans Affairs Medical Center...
  92. ncbi Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease
    Pablo Urena Torres
    Service de néphrologie et dialyse, Clinique de l Orangerie, Aubervilliers, France
    J Ren Nutr 16:253-8. 2006
    ..Its effectiveness on the control of PTH secretion, along with simultaneous reductions in calcium, phosphorus, and calcium-phosphorus product, give this agent an advantage over traditional therapies in all levels of severity of SHPT...
  93. ncbi [Pathophysiology and treatment of malignancy-associated hypercalcemia]
    Akimitsu Miyauchi
    Department of Medicine, National Hyogo-Chuo Hospital
    Nippon Rinsho . 2006
  94. ncbi [Therapy of hypercalcemia with ibandronate in case of acute renal failure]
    R Bergner
    Medizinische Klinik A, Klinikum der Stadt Ludwigshafen gGmbH, Bremserstrasse 49, Ludwigshafen
    Internist (Berl) 47:293-6. 2006
    ..This case report supports the results of other publications, that have reported the missing nephrotoxic effect of ibandronate compared to other bisphosphonates...
  95. ncbi [Hyperparathyroidism]
    Teruki Sone
    Department of Nuclear Medicine, Kawasaki Medical School
    Nippon Rinsho 63:229-32. 2005
  96. ncbi [Increased calcium as accidental finding]
    Helmut Reichel
    Nephrologisches Zentrum, Villingen-Schwenningen
    Med Klin (Munich) 100:486-94; quiz 495-6. 2005
  97. ncbi Clinical problem-solving. Back to basics
    Ilan Gabriely
    Division of Endocrinology and Metabolism, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA
    N Engl J Med 358:1952-6. 2008
  98. ncbi Megakaryoblastic transformation of polycythemia vera with hypercalcemia
    M Kurosawa
    Department of Internal Medicine, Sapporo Kosei Hospital, Kita-3, Higashi-8, Chuo-ku, Sapporo 060-0033, Japan. mikurosawa5211@ ima.me-h.ne.jp
    Ann Hematol 81:668-71. 2002
    ..b>Hypercalcemia is a serious complication of malignancies, but it is uncommon in acute leukemia...
  99. ncbi Current issues in hyperparathyroidism
    Greg A Krempl
    Department of Otorhinolaryngology, University of Oklahoma Health Sciences Center, P.O. Box 26902, WP1360, Oklahoma City, OK 73190, USA
    Otolaryngol Clin North Am 36:207-15. 2003
    ..years that has resulted in increasing numbers of patients being referred to surgeons with a diagnosis of hypercalcemia rather than primary hyperparathyroidism...
  100. ncbi Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism
    Manesh Parikshak
    Department of General Surgery, Henry Ford Hospital, Detroit, Michigan 48202, USA
    Am Surg 69:393-8; discussion 399. 2003
    ..We completed a retrospective review of 102 patients with primary hyperparathyroidism and mild hypercalcemia who underwent preoperative MIBI...
  101. ncbi Hypercalcemic complication in patients with oral squamous cell carcinoma
    M Iwase
    Second Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, 2 1 1 Kitasenzoku, Ota ku, Tokyo 145 8515, Japan
    Int J Oral Maxillofac Surg 32:174-80. 2003
    b>Hypercalcemia is one of the metabolic complications associated with cancer...

Research Grants79

  1. Ca2+-Sensing Receptor: Novel Roles in Calcium Homeostasis
    Edward M Brown; Fiscal Year: 2010
    ..The preliminary studies for this proposal have revealed striking Ca2+ intake-dependent hypercalcemia in the double KO mice (CaR-/-PTH-/-) compared to control mice (PTH KO, CaR+/+PTH-/-;and wild type, CaR+/+PTH+/+..
  2. Ca2+-Sensing Receptor: Novel Roles in Calcium Homeostasis
    Edward M Brown; Fiscal Year: 2009
    ..The preliminary studies for this proposal have revealed striking Ca2+ intake-dependent hypercalcemia in the double KO mice (CaR-/-PTH-/-) compared to control mice (PTH KO, CaR+/+PTH-/-; and wild type, CaR+/+PTH+/..
  3. ATF4 and Osteoclastogenesis
    Guozhi Xiao; Fiscal Year: 2010
    ..of new and more specific antiresorptive agents for treating patients with devastating osteoporosis, hypercalcemia of malignancy, and Paget's disease of bone...
  4. CONSTITUTIVELY ACTIVE PTH/PTHRP RECEPTORS IN VIVO
    HARALD JUEPPNER; Fiscal Year: 2000
    ..chondrodysplasia (JMC) is characterized by short stature due to impaired growth-plate maturation, and severe hypercalcemia and hypophosphatemia despite normal/undetectable parathyroid hormone (PTH) or PTH-related peptide (PTHrP)...
  5. Efficacy of 25-hydroxyvitamin D3 in colon cancer chemoprevention
    Rajendra Mehta; Fiscal Year: 2007
    ..However, 1,25(OH)2D3 causes hypercalcemia. In view of this numerous analogs of vitamin D have been synthesized...
  6. Efficacy of 25-hydroxyvitamin D3 in colon cancer chemoprevention
    Rajendra G Mehta; Fiscal Year: 2010
    ..However, 1,25(OH)2D3 causes hypercalcemia. In view of this numerous analogs of vitamin D have been synthesized...
  7. Efficacy of 25-hydroxyvitamin D3 in colon cancer chemoprevention
    Rajendra Mehta; Fiscal Year: 2009
    ..However, 1,25(OH)2D3 causes hypercalcemia. In view of this numerous analogs of vitamin D have been synthesized...
  8. Vitamin D and Colorectal Cancer
    Richard V Benya; Fiscal Year: 2010
    ..However 1,25(OH)2D3 causes hypercalcemia. We therefore synthesized a novel vitamin D analog, 11-hydroxy-24-ethyl-cholecalciferol [11(OH)D5]...
  9. Vitamin D and Colorectal Cancer
    RICHARD BENYA; Fiscal Year: 2009
    ..However 1,25(OH)2D3 causes hypercalcemia. We therefore synthesized a novel vitamin D analog, 11-hydroxy-24-ethyl-cholecalciferol [11(OH)D5]...
  10. ErbB1 signaling and cancer-mediated diseases of bone
    John Foley; Fiscal Year: 2006
    ..A large fraction of patients with this tumor present with malignancy-associated hypercalcemia. Hypercalcemia is a life-threatening disorder where patients suffer from a spectrum of neurological disorders, ..
  11. Treatment of Hypoparathyroidism with Parathyroid Hormone
    John P Bilezikian; Fiscal Year: 2010
    ..The large doses of calcium and vitamin D required are associated with risks of hypercalcemia, hypercalciuria and vitamin D toxicity...
  12. Breast Cancer Osteolysis--Regulation of PTHrP by TGFBeta
    Theresa Guise; Fiscal Year: 2005
    ..in patients with advanced disease to cause bone destruction (osteolytic metastases) and the associated pain, hypercalcemia, fracture and nerve compression syndromes...
  13. Evaluation of CYP24 as a Target for Enhancing Vitamin D*
    Donald Trump; Fiscal Year: 2006
    ..High dose dexamethasone (Dex) potentiates the antitumor effects and blunts calcitriol-induced hypercalcemia. Administration of high doses of calcitriol + Dex in men with advanced and early prostate cancer as well as ..
  14. Vitamin D in Prostate Cancer: Tumor Vasculature Effects
    Donald Trump; Fiscal Year: 2006
    ..we observed a 50 percent reduction in serum prostate specific antigen (PSA) in 28 percent of patients with no hypercalcemia; modulation of VDR and other potential markers of calcitriol activity in peripheral blood monocytes...
  15. Curcumin/Bioperine in Multiple Myeloma
    Saroj Vadhan Raj; Fiscal Year: 2005
    ..It is characterized by monoclonal gammopathy, hypercalcemia, renal failure, anemia, and increased susceptibility to infections...
  16. NOVEL AUREOLIC ACID TYPE ANTITUMOR AGENTS
    Jurgen Rohr; Fiscal Year: 2005
    ..is unique among anticancer agents in that it also has been used clinically to treat cancer-caused malignant hypercalcemia and Paget's bone disease...
  17. DESENSITIZATION AND DOWN REGULATION OF CALCIUM RECEPTORS
    Dolores Shoback; Fiscal Year: 2002
    ..Patients heterozygous for 1 abnormal CaR gene have mild hypercalcemia and hypocalciuria, while homozygotes are severely affected with life-threatening hypercalcemia and ..
  18. Proximal Tubule Transport Defect in Hyp Mice
    Michel Baum; Fiscal Year: 2007
    ..and 1,25(OH)2 vitamin D which results in improvement of rickets but can result in hyperparathyroidism, hypercalcemia, hypercalciuria and nephrocalcinosis...
  19. Pathophysiology of PTH-related Protein (1-36) in Humans
    Andrew Stewart; Fiscal Year: 2002
    ..the Applicant's Abstract): This application is a hormone-related protein (PTHrP) in the syndrome of humoral hypercalcemia of malignancy (HHM) and its potential therapeutic role in osteoporosis. PThrP is responsible for HHM...
  20. GENOTYPE/PHENOTYPE CORRELATIONS IN WILLIAMS SYNDROME
    CAROLYN MERVIS; Fiscal Year: 1999
    ..characterized by mild to moderate mental retardation, unique cognitive and personality profiles, infantile hypercalcemia, dysmorphic facial features, and supravalvular aortic stenosis (SVAS)...
  21. CA2+-RECEPTOR: IMMUNE MODULATION IN VIVO AND IN VITRO
    Edward M Brown; Fiscal Year: 2007
    ..The former is termed autosomal dominant hypocalcemia (ADH) and the latter familial hypocalciuric hypercalcemia (FHH)...